With expertise in epidemiology, health economics and health outcomes research, UBC provides sponsors with the data they need to make the strongest possible development decisions about their pharmaceutical or medical device products.
In this era of rigorous demands to demonstrate product value – and to identify potential risks and benefits – our scientists help you understand the impact of health science policies and regulations.
We also design and implement studies to quantify the economic burden of illness and evaluate treatment cost effectiveness. One component of this is to assess the impact of diseases and treatments from the patient perspective.
UBC focuses on:
- Providing an in-depth understanding of the impact of disease – including its treatment and care – on health-related quality of life and other patient-reported outcomes
- Using proven systematic literature review methods to gather efficacy and safety data
- Designing research and market-driven strategies to meet payers’ demands
In addition, our pricing and reimbursement analysts develop comprehensive launch-to-payer plans for firms in the United States.